TOPICAL TREATMENT OF RECURRENT HERPES SIMPLEX WITH CYTOSINE ARABINOSIDE
- 1 April 1975
- journal article
- shorter communication
- Published by AMPCo in The Medical Journal of Australia
- Vol. 1 (15) , 479-480
- https://doi.org/10.5694/j.1326-5377.1975.tb111504.x
Abstract
A double‐blind controlled clinical trial of the topical use of cytosine arabinoside in recurrent herpes simplex of the face and genital region showed no significant difference in the efficiency of a placebo as compared with cytosine arabinoside. The high rate of placebo response (70%) found in this trial makes the assessment of any drug treatment for herpes simplex particularly difficult.Keywords
This publication has 5 references indexed in Scilit:
- Adverse Effect of Cytosine Arabinoside on Disseminated Zoster in a Controlled TrialNew England Journal of Medicine, 1973
- DEMONSTRATION TO MEDICAL STUDENTS OF PLACEBO RESPONSES AND NON-DRUG FACTORSThe Lancet, 1972
- TOPICAL IDOXURIDINE IN RECURRENT HERPES SIMPLEX: With a Note on Its Effect on Early Varicella *Annals of the New York Academy of Sciences, 1970
- The effect of cytosine arabinoside on the replication of herpes simplex virusVirology, 1967
- Herpes SimplexDermatology, 1965